住院患者醒脑静注射液使用情况调查

摘要

目的 调查住院患者醒脑静注射液使用情况,为促进其合理应用提供参考.方法 回顾性随机抽查某院2014年1月-2015年6月神经内科186份使用了醒脑静注射液的住院病历,对其用法、用量和用药目的进行统计分析.结果 该科醒脑静注射液存在超说明书用药情况,其中超剂量给药占59.7%,单次用药剂量为40 mL占13.4%;溶媒选择不当占49.5%;与西药注射剂配伍使用占54.8%,其中与氯化钾联用占47.8%.结论 临床使用醒脑静注射液存在不合理情况,应加强其规范使用管理.%Objective To investigate the application of xingnaojing injections ( XNJI) in inpatients and further provide a reference for the rational drug use. Methods The retrospective investigation was carried out by reviewing 186 hospitalization records with XNJI from a certain hospital from January 2014 to June 2015. The usage, dosage, and indication of XNJI were analyzed. Results Unlabeled use of XNJI was found in the neurology department inpatients. 59. 7% inpatients were treated with overdosed XNJI, and 13. 4% were treated with a single drug dose of 40 mL. The inappropriate solvent selection accounted for 49. 5%. Compatibility of XNJI and western medicine injection accounted for 54. 8%. It was also found that XNJI was used together with potassium chloride in clinic (47. 8%). Conclusion There exist some irrational uses of XNJI in clinic, thus the use and management of traditional Chinese medicine injections should be standarized.